Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

3 Late-Season Earnings Plays for Mid-Cap Traders: https://www.marketbeat.com/logos/articles/med_20230531075618_3-late-season-earnings-plays-for-mid-cap-traders.jpg
3 Late-Season Earnings Plays for Mid-Cap Traders

As June rolls around, amusement parks and beachside cabanas are getting worked into the budgets of vacation-hungry Americans. For U.S. stock traders, summer’s kickoff coincides with the conclusion

Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery
Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery

-          An innovative covalent platform for precision targeting of disease-causing proteins

 

-          Seed financing led by RA Capital Management, Droia Ventures, and Novartis Venture

KB Home Constructs Bullish Price Action As Wider Industry Thrives
KB Home Constructs Bullish Price Action As Wider Industry Thrives

Key Points

  • High interest rates are keeping homeowners in place, boosting homebuilders’ stocks.
  • KB Home, a Los Angeles-based midcap, shows potential for further gains as it consolidates in a